S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

TransMedics Group, Inc. Common Stock

TMDX XNAS
$67.84 -4.60 (-6.31%) ▼ 15-min delayed
Open
$72.54
High
$72.73
Low
$67.69
Volume
2.70M
Market Cap
$2.34B

About TransMedics Group, Inc. Common Stock

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Sector: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Employees: 898 Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $173.93M $7.32M $0.21
FY 2025 $605.49M $190.29M $5.60
Q3 2025 $143.82M $24.32M $0.71
Q2 2025 $157.37M $34.91M $1.03

Related Market News

No specific coverage for TMDX yet. Check out our latest market news or earnings calendar.

Get TMDX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on TransMedics Group, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.